# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040588
Filing Date
2023-08-09
Accepted
2023-08-09 16:12:21
Documents
65
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | rptx-20230630.htm iXBRL | 10-Q | 2990865
2 | EX-10.1 | rptx-ex10_1.htm | EX-10.1 | 37022
3 | EX-10.2 | rptx-ex10_2.htm | EX-10.2 | 67465
4 | EX-31.1 | rptx-ex31_1.htm | EX-31.1 | 20490
5 | EX-31.2 | rptx-ex31_2.htm | EX-31.2 | 20225
6 | EX-32.1 | rptx-ex32_1.htm | EX-32.1 | 10361
7 | EX-32.2 | rptx-ex32_2.htm | EX-32.2 | 10549
| Complete submission text file | 0000950170-23-040588.txt |  | 10210489

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | rptx-20230630_cal.xml | EX-101.CAL | 40861
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | rptx-20230630.xsd | EX-101.SCH | 45141
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | rptx-20230630_pre.xml | EX-101.PRE | 293202
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | rptx-20230630_lab.xml | EX-101.LAB | 388700
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | rptx-20230630_def.xml | EX-101.DEF | 141783
59 | EXTRACTED XBRL INSTANCE DOCUMENT | rptx-20230630_htm.xml | XML | 2252932

Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39335 | Film No.: 231155280
SIC: 2834 Pharmaceutical Preparations